
### [NCIT:C136612](http://purl.obolibrary.org/obo/NCIT_C136612)
**Label:** Bone Cancer by AJCC v8 Stage

**Subclasses:** [NCIT:C136613](http://purl.obolibrary.org/obo/NCIT_C136613) (Stage I Bone Cancer AJCC v8), [NCIT:C136620](http://purl.obolibrary.org/obo/NCIT_C136620) (Stage IV Bone Cancer AJCC v8), [NCIT:C136616](http://purl.obolibrary.org/obo/NCIT_C136616) (Stage II Bone Cancer AJCC v8), [NCIT:C136619](http://purl.obolibrary.org/obo/NCIT_C136619) (Stage III Bone Cancer AJCC v8), 

**Class expressions from DL-Learner:**

- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 58.33%
- Thing 51.96%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39803](http://purl.obolibrary.org/obo/NCIT_C39803) (PRCC-TFE3 Fusion Protein Expression))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39801](http://purl.obolibrary.org/obo/NCIT_C39801) (inv(X)(p11;q12)))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 43.69%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 43.69%


